CD4 and colitis: In addition to the beneficial effects of butyrate on limitation of proinflammatory potential of neutrophils, amelioration of colitis by butyrate may also be associated with promoting CD4+ T cell production of IL-10 and IL-22,8,10 boosting macrophage antimicrobial program9 and strengthening epithelial barrier integrity.4